Technical Articles
FITC-labeled
FITC-Labeled CD7 His Tag Protein: A Core Tool for Decoding T Cell-Related Disease Research and Therapy
FITC-Labeled CD7 His Tag Protein is a recombinant detection tool consisting of the extracellular domain of the T-cell surface marker CD7 fused with a histidine tag and covalently labeled with fluorescein isothiocyanate (FITC). As a specific probe for a key marker of T lymphocyte and NK cell activation, it holds irreplaceable value in the diagnosis and classification of T-cell acute lymphoblastic leukemia, certain autoimmune diseases, immunodeficiency disorders (such as HIV infection), and the development of cutting-edge cell therapies.
View details
- Cancer
- CD7 protein
- FITC-labeled
- His tag
- T-cell acute lymphoblastic leukemia (T-ALL)
FITC-Labeled CEACAM-5/CD66e Fc Chimera Protein: Decoding the Core Fluorescent Probe for Adenocarcinoma Diagnosis and Therapy
FITC-Labeled CEACAM-5/CD66e Fc Chimera is a recombinant protein tool consisting of the extracellular domain of human carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM-5/CD66e) fused to the Fc fragment of immunoglobulin G (IgG) and labeled with fluorescein isothiocyanate (FITC).
View details
- Cancer
- CEACAM-5
- CD66e
- Carcinoembryonic Antigen (CEA)
- FITC-Labeled
- Fc Fusion Protein
- Colorectal Cancer
FITC-Labeled CD38 Fc Chimera Protein: Decoding the Core Fluorescent Probe for Immunomodulation, Cancer, and Aging Research
FITC-Labeled CD38 Fc Chimera is a recombinant protein tool that combines the extracellular domain of human CD38 with the Fc fragment of immunoglobulin G (IgG) and is labeled with fluorescein isothiocyanate (FITC). As a specific detection probe for the multifunctional immunomodulatory receptor CD38, it is non-pathogenic but serves as a core experimental reagent in key disease research areas such as multiple myeloma, autoimmune diseases, metabolic disorders, viral infections, and age-related immune decline.
View details
- Cancer
- CD38 Protein
- FITC-Labeled
- Fc Fusion Protein
- Multiple Myeloma
- Daratumumab
- Flow Cytometry
- 1














